|
|
|
|
New data show high benefits of pramipexole in patients with advanced Parkinsons disease
New data presented at the Movement Disorder Societys 13th International Congress of Parkinsons Disease and Movement Disorders (MDS) further confirms the high therapeutic benefit of mirapexin (pramipexole) once-daily,...
|
|
|
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand break
1 Laboratory of Molecular Pharmacology, National Cancer Institute, Building 37, Room 5068, NIH, Bethesda, MD 20892-4255, USA 2 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892,...
|
|
|
Extended release pramipexole as effective as immediate release formulation
A new extended release formulation of pramipexole is as effective as the immediate release formulation, according to data presented at the 13th International Congress of Parkinsons Disease and Movement Disorders held in Paris...
|
|
|
THAP1 Mutations Found in Many Primary Dystonias
In two new papers, investigators reported that THAP1 mutations may be the leading defects in most cases of primary dystonia.SEATTLE-From a zip code on chromosome 8 found in 1997 in two Amish-Mennonite families with a history of DYT6...
|
|
|
Movement Disorder Society (MDS) 13th International Congress of Parkinson's Disease and Movement Disorders
_ Movement Disorder Society (MDS) 13th International Congress of Parkinson's Disease and Movement Disorders.
|
|
|
What Is Narcolepsy? What Causes Narcolepsy?
Narcolepsy - from the French narcolepsie, which was derived from the Greek narke meaning numbness and lepsis meaning attack or seizure - is a chronic sleep disorder where the brain is unable to regulate the body's sleep-wake cycles.People...
|
|
|
Are the adverse effects of body position in patients with obstructive sleep apnea dependent on sleep stage
Print Save in My Library Free Abstract Mador MJ et al.- The authors found significant effects of both sleep stage and body position in mild and moderate but not severe OSA. Patients with moderate and severe OSA were less likely to spend...
|
|
|
Clinical spectrum of ataxia-telangiectasia in adulthood
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Neurology, 06/18/09 Print Save in My Library Free Abstract Verhagen MMM et al.- Ataxia-telangiectasia (A-T) should be considered in patients with...
|
|
|
Telemedicine expands reach of care for Parkinson's patients
A unique and innovative telemedicine project is providing distant nursing home patients with Parkinson's disease access to neurologists at the University of Rochester Medical Center.A pilot study of the project - the results of which were...
|
|
|
AAN 2009: What's New in Parkinson's Disease and Movement Disorders
_ AAN 2009: What's New in Parkinson's Disease and Movement Disorders.
|
|
|
People With Huntington's Report Discrimination
FRIDAY, June 12 (HealthDay News) -- As if having a family history of an incurable genetic disease isn't worry enough, people with a family history of Huntington's disease report being discriminated against by insurance companies, relatives...
|
|
|
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly I
- Data Presented at the 13th International Congress of Parkinson's Disease and Movement Disorders - Long-term Treatment With rotigotine was Generally Well Tolerated in Patients With Early Stage Parkinson&apos...
|
|
|
Gabapentin Enacarbil Improves Functioning, Quality of Life, and Mood in Patients With Primary Restless Legs Sy
my personal edition> restless legs syndrome > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Gabapentin enacarbil was effective in improving symptoms in patients with primary restless legs...
|
|
|
Patients Treated With Preladenant for Parkinson's Disease Experience Reduced 'Off' Time and Increased 'On' Tim
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Preladenant controls symptoms associated with 'wearing off' in patients with moderate to severe Parkinson's...
|
|
|
Istradefylline Well Tolerated, Improves Motor Function During 'On' State in Patients Receiving Levodopa for Pa
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Patients who have Parkinson's disease (PD) with motor complications from levodopa therapy demonstrate...
|
|
|
Zonisamide Safe and Effective in Long-Term Treatment of Parkinson's Disease: Presented at MDS
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Long-term treatment with zonisamide is safe and effective in controlling the symptoms of Parkinson's disease (PD...
|
|
|
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly I
BRUSSELS, June 12 /PRNewswire/ -- - For the Attention of European Accredited Medical Writers Only - Data Presented at the 13th International Congress of Parkinson's Disease and Movement Disorders - Long-term Treatment With...
|
|
|
New Data Shows Requip-Modutab Improves Nocturnal Symptoms in Patients with Advanced Parkinson's Disease
4025 live jobs on PharmiWeb.com now Not for distribution in the USA Information for medical journalists only Embargoed until 11:30 BST, 11th June, 2009 London, 11:30 BST, 11th June, 2009: New data presented at the 13th International Congress...
|
|
|
New Data Shows Requip-Modutab Improves Nocturnal Symptoms In Patients With Advanced Parkinson's Disease
New data presented at the 13th International Congress of Parkinson's Disease and Movement Disorders show that Requip-Modutab* (ropinirole prolonged release tablets) improves nocturnal symptoms experienced by patients with...
|
|
|
Istradefylline Well Tolerated, Improves Motor Function During 'On' State in Patients Receiving Levodopa for Pa
-- Patients who have Parkinson's disease (PD) with motor complications from levodopa therapy demonstrate significant improvement in motor function with istradefylline, according to a study reported here at the Movement Disorder Society...
|
|
|
Zonisamide Safe and Effective in Long-Term Treatment of Parkinson's Disease: Presented at MDS
-- Long-term treatment with zonisamide is safe and effective in controlling the symptoms of Parkinson's disease (PD) in patients, without those patients developing disabling dyskinesia, researchers reported here at the Movement...
|
|
|
Study Supports Mirapexin and Sifrol for Parkinsons Disease
Trial data presented at the Movement Disorder Societys 13th International Congress of Parkinsons Disease and Movement Disorders in Paris, France, has further supported the therapeutic benefits of Mirapexin with Sifrol.
|
|
|
UCB says data shows rotigotine improved early morning akinesia in patients with advanced Parkinson's disease
AM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - UCB (UCBJF.PK: News ) said clinical data presented at the 13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France showed that rotigotine improved...
|
|
|
People With Huntington's Report Discrimination
FRIDAY, June 12 (HealthDay News) -- As if having a family history of an incurable genetic disease isn't worry enough, people with a family history of Huntington's disease report being discriminated against by insurance companies, relatives...
National Womens Health Information Center:
Jun 12 2009 6:31PM
Matching: movement disorders
|
Find similar documents
|
|
|
|
Donepezil Treatment Reduces the Risk of Falls in Patients With Parkinson's Disease: Presented at MDS
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 10, 2009 -- Patients with Parkinson's disease (PD) treated with donepezil have as much as a 50% reduction in falls, thus...
|
